Cencora, Inc. today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock Exchange. The ...
Zacks.com on MSN1d
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
StockStory.org on MSN3d
Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers StocksAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...
Cencora COR +0.57% Get Free Report has outperformed the market over the past 10 years by 7.55% on an annualized basis ...
According to a Bloomberg report, the French-based Walden Group, a company specializing in pharmaceutical logistics, is ...
Germany’s DHL Group and US logistics firm Cencora Inc. are among the potential suitors for Walden Group, which specializes in transporting pharmaceutical products, according to people familiar with ...
Chainlink, the standard for onchain finance, BGD Labs, a Web3 development initiative focused on the Aave ecosystem, and Aave ...
Germany’s DHL Group and US logistics firm Cencora Inc. are among the potential suitors for Walden Group, which specializes in transporting pharmaceutical products, according to people familiar ...
AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...
Zacks Investment Research on MSN12h
Here's Why You Should Retain OPKO Health Stock in Your PortfolioOPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback